Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Treasury Shares: 2017-2024

Historic Treasury Shares for Cidara Therapeutics (CDTX) over the last 8 years, with Dec 2024 value amounting to $177,273.

  • Cidara Therapeutics' Treasury Shares rose 86.16% to $367,004 in Q3 2025 from the same period last year, while for Sep 2025 it was $367,004, marking a year-over-year increase of 86.16%. This contributed to the annual value of $177,273 for FY2024, which is 69.01% up from last year.
  • According to the latest figures from FY2024, Cidara Therapeutics' Treasury Shares is $177,273, which was up 69.01% from $104,886 recorded in FY2023.
  • In the past 5 years, Cidara Therapeutics' Treasury Shares registered a high of $1.2 million during FY2022, and its lowest value of $104,886 during FY2023.
  • Its 3-year average for Treasury Shares is $502,010, with a median of $177,273 in 2024.
  • In the last 5 years, Cidara Therapeutics' Treasury Shares soared by 174.17% in 2021 and then plummeted by 91.43% in 2023.
  • Cidara Therapeutics' Treasury Shares (Yearly) stood at $428,235 in 2020, then soared by 174.17% to $1.2 million in 2021, then climbed by 4.24% to $1.2 million in 2022, then crashed by 91.43% to $104,886 in 2023, then soared by 69.01% to $177,273 in 2024.